Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer.

Sci Rep · 2021 · PMC8608842 · PMID 34811396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Exosomes levels decreased in mCRC patients after therapy and increased during disease progression although differences did not reach statistical significance (Fig. 1 b).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.